New Infant RSV Prevention to be Available this Fall
In the United States, a new monoclonal antibody (nirsevimab; trade name: Beyfortus) was recently approved by the FDA and recommended by the CDC… read more
In the United States, a new monoclonal antibody (nirsevimab; trade name: Beyfortus) was recently approved by the FDA and recommended by the CDC… read more
Coal Combustion Residuals (CCRs) are generated from the combustion of coal in producing steam for generation of electricity by electric utilities and independent… read more
ToxStrategies LLC is excited to announce that Modality Solutions is joining forces with our firm, greatly expanding our ability to serve the evolving needs of… read more
EpidStrategies is excited to be attending and presenting at The International Society for Pharmacoepidemiology’s (ISPE) 39th Annual Meeting (ICPE 2023), August 23rd through… read more
Dr. Rayetta Henderson will provide witness testimony during the “Hemp in the Modern World: The Yearslong Wait for FDA Action” hearing to be… read more
Dr. Frankenfeld is an expert in nutritional epidemiology research and has conducted primary data collection research and secondary data analysis using population-based data… read more
We are pleased to announce that a leading expert in the field of developmental and reproductive toxicology (DART), and juvenile toxicology—Dr. Gregg Cappon—has… read more
ToxStrategies food defense expert Dr. Jennifer van de Ligt and co-author Ned Mitenius have written chapters on food defense that are included in… read more